|About the DAN||Members||Public Service Awards||Progress and Impact|
The Dystonia Advocacy Network (DAN) is a grassroots organization that brings dystonia-affected individuals together to speak out with a single, powerful voice on legislative and public policy issues which impact the dystonia community.
The DAN was established in 2007 in order to leverage our resources for maximum effect in the legislature. No matter what type of dystonia you have, the DAN ensures that your voice will work in concert with other dystonia advocates on legislative initiatives which benefit all dystonia patients.
The DAN has the following responsibilities:
- Develop, implement and manage a legislative and policy agenda to meet the needs of the dystonia community.
- Develop and manage the communications and resources necessary to achieve legislative goals.
- Speak with a united voice for the dystonia community.
- Develop, implement and manage a system of legislative advocates to achieve legislative goals;
- Monitor and track legislative issues relative to issues pertaining to the dystonia community;
- Develop and maintain Congressional relationships and identify dystonia champions;
- Develop and oversee the use of advocacy tools;
- Evaluate annually the effectiveness of actions and activities; and
- Explore areas of collaboration.
Dystonia advocates develop relationships with their legislative leaders to help them understand the challenges of those living with dystonia.
The Dystonia Advocacy Network (DAN) welcomes and represents individuals with all forms of dystonia, and is led by the following dystonia organizations:
The mission of the Benign Essential Blepharospasm Research Foundation, Inc. is to fund and promote medical research in the search for the cause and cure of blepharospasm, Meige, and other related disorders of the facial musculature, to provide support, education and referrals to persons with these disorders, and to disseminate information and serve as an authoritative resource to the medical community and the general public.
The mission of the Dystonia medical Research Foundation is to advance research for more treatments and ultimately a cure, to promote awareness and education, and to support the needs and well-being of affected individuals and families.
The National Spasmodic Dysphonia Association (NSDA) is dedicated to improving the lives of people affected by spasmodic dysphonia and related voice conditions throgh research, education, awareness, and support.
The mission of the National Spasmodic Torticollis Association (NSTA) is to support the needs and well being of affected individuals and families; to promote awareness and education; to advance research for more treatments and ultimately a cure.
When a Member of Congress identifies himself/herself as a true champion of the dystonia community by going above and beyond to improve the health of dystonia patients, they are presented with the DAN Distinguished Public Service Award. This exemplary service can range from raising critical awareness of dystonia to using a political office to bolster research or improve patient care. Over the years, the DAN Distinguished Public Service Award has been presented to Senators and Representatives, Democrats and Republicans. The common thread that links all award recipients together is that they respond to the needs of the dystonia community not just as elected officials, but as caring friends who want to help.
Department of Defense Facilitates Dystonia Research
Medical literature has identified a link between traumatic injuries and the onset of dystonia. Traumatic injuries and subsequent dystonia are constant threats to our military personnel. Dystonia advocates work tirelessly to ensure that the Department of Defense (DOD) and its medical research program is a stakeholder in the fight to improve treatment options for our dystonia-affected veterans. Congressional outreach and education by dystonia advocates across the country resulted in legislators adding “dystonia” to the list of conditions deemed eligible for study through the DOD Peer-Reviewed Medical Research Program.
Expansion of the Dystonia Research Portfolio at National Institutes of Health
Each year dystonia advocates encourage Congress to significantly increase funding for the National Institutes of Health (NIH) and support expansion of the dystonia research portfolio at NIH. This sustained outreach has helped funding for dystonia research at NIH grow.
Over past years Congress has been working to establish an approval pathway for follow-on or generic biologic products at the Food and Drug Administration (FDA) (botulinum toxin is a biologic). Dystonia advocates educated their legislators about the potential dangers of poorly regulated toxic products and encouraged them to adopt an approval pathway with significant patient safety provisions. Congress responded in 2010 by establishing a follow-on biologics approval pathway at FDA that includes strict patient safety standards.
Genetic Information Nondiscrimination Act
In 2008 Congress passed, and the president signed, the Genetic Information Nondiscrimination Act (P.L. 110-223). GINA, for short, is a critical piece of civil rights legislation that encourages individuals to better manage their health by undergoing testing to learn of predispositions to, or the development of, certain genetic conditions by making it illegal for employers and insurers to use the results of those tests to discriminate against the individual. After being hung-up in the legislative process for close to a decade, a groundswell of support by the patient community saw that GINA was ultimately passed by a vote of 414 to 1 in the House and 95 to 0 in the Senate.